Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CD11301 |
Synonyms | |
Therapy Description |
CD11301 is a topical gel containing resiquimod, a Toll-like receptor (TLR) agonist that may activates TLR signaling, leading to enhanced T-cell immune response (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CD11301 | CD-11301|CD 11301 | CD11301 is a topical gel containing resiquimod, a Toll-like receptor (TLR) agonist that may activates TLR signaling, leading to enhanced T-cell immune response (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03292406 | Phase II | CD11301 | A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) (CTCL) | Completed | USA | FRA | DEU | 0 |